You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.


Go back

Welcome to GSK’s Ellipta Commissioning Hub

This site has been designed to support commissioners and healthcare professionals when making an asthma or COPD formulary application.

Here you’ll find information regarding the clinical evidence and cost of the Ellipta range of medicines to help you with your strategic planning and procuring of services.

Ellipta is a registered trademark of the GlaxoSmithKline group of companies